Resale Registration Filed for 4.9M Shares from Deeply Discounted Private Placement
CODX has more than doubled off its 52-week low of $1.26 on elevated volume (3.0× avg).
Summary
Co-Diagnostics filed an S-3 to register the resale of 4.9 million shares and warrants from a recent deeply discounted private placement, potentially increasing outstanding shares by over 134% and providing critical, albeit dilutive, capital for a company facing a 'going concern' warning.
Key Events · Financing and Capital Events · CODX
-
Resale Registration for 4.9 Million Shares
Co-Diagnostics filed an S-3 registration statement for the resale of 4,942,341 shares of common stock by selling stockholders. These shares were issued in a private placement on May 21, 2026, and include PIPE shares, pre-funded warrant shares, and common warrant shares.
-
Significant Potential Dilution
The 4,942,341 shares registered for resale represent approximately 134% of the 3,685,314 shares currently outstanding. If all these shares are sold, it would create substantial dilution and a significant overhang on the stock price.
-
Potential Proceeds from Warrant Exercise
The company will not receive proceeds from the resale of shares. However, it could receive approximately $5.18 million if all warrants (including common warrants exercisable at $1.571 per share) are exercised for cash, which would be used for working capital and general corporate purposes.
-
Deeply Discounted Private Placement
The common warrants from the underlying private placement are exercisable at $1.571 per share, a deep discount compared to the last reported sale price of $7.30 per share on May 27, 2026. This indicates the challenging terms of the recent capital raise.
Analysis · CODX · Industrial Applications And Services
This S-3 filing registers for resale approximately 4.9 million shares of common stock and warrants issued in a private placement on May 21, 2026. This represents a potential increase of over 134% to the current outstanding shares, creating a significant overhang on the stock. The underlying private placement involved common warrants exercisable at a deep discount ($1.571 per share) compared to the recent market price of $7.30, indicating the company's urgent need for capital amidst its 'going concern' warning. While the company will not receive proceeds from the resale, it could receive approximately $5.18 million if all warrants are exercised for cash, which is critical for its liquidity.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CODX was trading at $10.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $40.3M. The 52-week trading range was $1.26 to $46.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.